291 related articles for article (PubMed ID: 24330809)
1. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ
Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.
Liu Y; Zhou Y; Feng X; An P; Quan X; Wang H; Ye S; Yu C; He Y; Luo H
Int J Oncol; 2014 Jan; 44(1):203-10. PubMed ID: 24189753
[TBL] [Abstract][Full Text] [Related]
3. Role of visfatin in promoting proliferation and invasion of colorectal cancer cells by downregulating SDF-1/CXCR4-mediated miR-140-3p expression.
Zhao Q; Li JY; Zhang J; Long YX; Li YJ; Guo XD; Wei MN; Liu WJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5367-5377. PubMed ID: 32495871
[TBL] [Abstract][Full Text] [Related]
4. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
[TBL] [Abstract][Full Text] [Related]
5. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo.
Hu G; Chen D; Li X; Yang K; Wang H; Wu W
Cancer Biol Ther; 2010 Jul; 10(2):190-7. PubMed ID: 20505319
[TBL] [Abstract][Full Text] [Related]
6. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.
Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H
Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280
[TBL] [Abstract][Full Text] [Related]
7. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
[TBL] [Abstract][Full Text] [Related]
8. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
[TBL] [Abstract][Full Text] [Related]
9. Circ_0007031 enhances tumor progression and promotes 5-fluorouracil resistance in colorectal cancer through regulating miR-133b/ABCC5 axis.
He X; Ma J; Zhang M; Cui J; Yang H
Cancer Biomark; 2020; 29(4):531-542. PubMed ID: 32865180
[TBL] [Abstract][Full Text] [Related]
10. Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer.
Zheng X; Ma YF; Zhang XR; Li Y; Zhao HH; Han SG
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4190-4202. PubMed ID: 32373955
[TBL] [Abstract][Full Text] [Related]
11. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
12. MiR-146a suppresses the expression of CXCR4 and alters survival, proliferation and migration rate in colorectal cancer cells.
Afshar-Khamseh R; Javeri A; Taha MF
Tissue Cell; 2021 Dec; 73():101654. PubMed ID: 34601384
[TBL] [Abstract][Full Text] [Related]
13. MiR-133b inhibits colorectal cancer metastasis via lncRNA-LUCAT1.
Ma M; Li L; Long F; Xiao H; Lu M; Lin C
Future Oncol; 2021 Mar; 17(9):1013-1023. PubMed ID: 33541136
[No Abstract] [Full Text] [Related]
14. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
Yu L; Lu Y; Han X; Zhao W; Li J; Mao J; Wang B; Shen J; Fan S; Wang L; Wang M; Li L; Tang J; Song B
Stem Cell Res Ther; 2016 Dec; 7(1):180. PubMed ID: 27906093
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
Sun K; Wang W; Zeng JJ; Wu CT; Lei ST; Li GX
Acta Pharmacol Sin; 2011 Mar; 32(3):375-84. PubMed ID: 21278784
[TBL] [Abstract][Full Text] [Related]
17. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
Xiang KM; Li XR
Asian Pac J Cancer Prev; 2014; 15(8):3767-72. PubMed ID: 24870791
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
20. Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma.
Sun K; Su G; Deng H; Dong J; Lei S; Li G
Chin Med J (Engl); 2014; 127(10):1884-90. PubMed ID: 24824250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
